Could weak muscles mean higher bleeding risk for seniors on blood thinners?
NCT ID NCT07173075
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether older adults (70+) with low muscle mass are more likely to have serious bleeding while taking common blood thinners (apixaban or rivaroxaban). Researchers will compare muscle mass in 110 patients who had a bleeding event with those who did not. The goal is to see if simple muscle measurements can help predict bleeding risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify elderly patients at higher risk of bleeding while on blood thinners, potentially leading to safer prescribing.
- What could go wrong
- This is an observational study with only 110 participants, so it cannot prove cause and effect. Results may not apply to all older adults or other blood thinners.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENUTRITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- Can nerve changes explain Age-Related muscle loss?
- Muscle loss in aging: can diet and exercise turn back the clock?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect